Genta Incorporated: Premium Company Profile

Questions: Discounts, Updates etc.

Price: $495.00

Publication Date: 2007-12-18

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

Genta, a clinical development stage biopharmaceutical company, aims to build on its core competitive strength of oncology development expertise in providing biopharmaceutical products for the treatment of cancer and to expand the pipeline of products in two therapeutic categories, DNA/RNA Medicines and Small Molecules, through internal development, licensing and acquisitions.


Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Report Highlights
    Genta, a biopharmaceutical company, is engaged in the identification, development, and commercialization of drugs for the treatment of cancer and related diseases in the US. The company's research portfolio consists of two programs, DNA/RNA Medicines and Small Molecules.

    Genta's total revenues decreased at a CAGR of 33% during 2002-2006, from $4 million in 2002 to $1 million in 2006. The company's biggest contributor to revenue during 2002-2006 was development funding under the agreement with Aventis.

    Unless Genasense receives approval, the company's only revenue source out to 2010 will be Ganite sales. Revenues from Ganite sales are expected to decrease at a CAGR of 9%, from $0.7 million in 2006 to $0.5 million in 2010, which is attributable to reduced spending and focus on the development, sale and marketing of Ganite by the company.


    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    Other users found this report page using the following search terms: genta history incorporated genasense sharepriceongenta company market forecast pharmag4460 information

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


    Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.